The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic ...

The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in adolescents aged 13 to 17 years.